FDA: Rapid Antigen COVID-19 Tests At Risk For False Positives

An alert from the agency warns that the tests, which have become widely used for their speed and portability, carry a risk of false positives.

Coronavirus

Rapid antigen tests for COVID-19 may carry a significantly high risk for false positive results, the US Food and Drug Administration announced on 3 November.

The agency sent an alert to caregivers and laboratory staff stating that the tests may give false positive results,...

More from United States

More from North America